Indian Army pharmaceutical tender for Oncology/Infectious Drugs & Anticancer Injectables in India 2026

Tender Overview

The Indian Army, Department Of Military Affairs, invites bids for a broad range of oncology injectables and related medical items across 23 line items, including Paclitaxel, Carboplatin, 5-Fluorouracil, Cisplatin, Docetaxel, Pegylated Liposomal Doxorubicin, Doxorubicin, Ifosfamide, Mesna, Vincristine, Bleomycin, Pemetrexed, Irinotecan, Epirubicin, Axitinib, Pertuzumab and Trastuzumab. The procurement aims to ensure medical continuity for combat and casualty care. The estimated value is not disclosed; the EMD is ₹442,260. The BBQR specification and supplier compliance are mandatory, with a required brochure before bid opening and OEM authorizations. Shelf-life treatment favors indigenous drugs with 5/6 of shelf life remaining; foreign products must maintain 2/3. A delivery and stock replacement policy governs remaining stock and defective items. Location for submission is Kolkata, with strict adherence to BBQR for 23 items and exclusive use of medicines rather than health supplements.

Technical Specifications & Requirements

• Product categories: Oncology injectables and chemotherapeutic agents; includes Paclitaxel 100 mg Inj, Paclitaxel 30 mg Inj, Carboplatin 150 mg Inj, 5-Fluorouracil 500 mg/10 ml Inj, Cisplatin 50 mg Inj, Docetaxel variants, Doxorubicin formulations, Bleomycin, Ifosfamide, Mesna, Vincristine, Pemetrexed, Irinotecan, Ep irubicin, Axitinib 5 mg, and Pertuzumab/Trastuzumab 600 mg each.
• Standards / compliance: BBQR-compliant; indigenous drugs shelf-life policy; OEM authorization; MII / past performance documents; exclusive compliance with BBQR specifications; no substitutes for medicines unless explicitly asked; stock replacement within 3 months of expiry; warranty/defect replacement obligations.
• Delivery / scope: 23 items with delivery in line with original delivery order; option to increase quantity up to 50% during contract at contracted rates; extended delivery period rules apply if options exercised; address for brochure submission via GeM Med channel is Kolkata.
• Documentation: OEM authorization, turnover evidence, past performance, and compliance certificates must be uploaded; brochure submission to OIC GeM (Med), Command Hospital (EC), Alipore, Kolkata.

Terms, Conditions & Eligibility

• EMD: ₹442,260 to be submitted as specified in tender terms.
• Option clause: quantity may increase/decrease by up to 50%; delivery periods extend proportionally with a minimum of 30 days.
• Shelf-life policy: indigenous drugs keep 5/6th of shelf life; foreign products maintain 2/3; acceptance at CFA discretion.
• Replacement: replace unconsumed stock before expiry; replace defective stock within shelf life.
• Documentation: submit GST, PAN, OEM authorizations, experience, financials, and BBQR compliance; failure results in rejection.
• Delivery / payment terms: terms aligned with BBQR; no health supplements in place of medicines unless requested.